Ethiopia

v. 13 – 2020/01

Market Executive Summary Roadmap announced and Traceability Pilot underway: Food and Medicine Administration Proclamation 1112/2019

Codified as Directive “Pharmaceutical Products Traceability Directive No.43/2019”, published 19 August 2019

Scope is defined as “1. All pharmaceutical products registered in Ethiopia which are intended for human use” as well as “prescribed medicines, program medicines and medicines easily exposed to counterfeiting.”

Key Dates Proposed timeline:

  • July 2021: Barcode with Product Identifier and master data sharing (no details)
  • July 2022: 3-element GS1 DataMatrix: GTIN / Hatch Nbr / Exp and pilot (no detail)
  • July 2024: 4-element GS1 DataMatrix, including Serial Number